DEPOTXA

Serial Number 87071996
606

Registration Progress

Application Filed
Jun 15, 2016
Under Examination
Jan 17, 2017
Approved for Publication
Nov 22, 2016
Published for Opposition
Nov 22, 2016
Registered

Basic Information

Serial Number
87071996
Filing Date
June 15, 2016
Published for Opposition
November 22, 2016
Abandonment Date
August 19, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 19, 2019
Classes
005

Rights Holder

Pacira Pharmaceuticals, Inc.

03
Address
10578 Science Center Drive, Suite 125
San Diego, CA 92121

Ownership History

Pacira Pharmaceuticals, Inc.

Original Applicant
03
San Diego, CA

Pacira Pharmaceuticals, Inc.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
Vanessa A. Ignacio, Esquire

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

32 events
Date Code Type Description
Aug 19, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Aug 19, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 10, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 8, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 8, 2019 EXT4 S SOU EXTENSION 4 FILED
Jan 8, 2019 EX4G S SOU EXTENSION 4 GRANTED
Jul 14, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 12, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 12, 2018 EXT3 S SOU EXTENSION 3 FILED
Jul 12, 2018 EX3G S SOU EXTENSION 3 GRANTED
Jan 4, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 2, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 2, 2018 EXT2 S SOU EXTENSION 2 FILED
Jan 2, 2018 EX2G S SOU EXTENSION 2 GRANTED
May 25, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 23, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
May 23, 2017 EXT1 S SOU EXTENSION 1 FILED
May 23, 2017 EX1G S SOU EXTENSION 1 GRANTED
Jan 17, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 22, 2016 PUBO A PUBLISHED FOR OPPOSITION
Nov 22, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 17, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 14, 2016 ALIE A ASSIGNED TO LIE
Sep 28, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 27, 2016 CNEA R EXAMINERS AMENDMENT -WRITTEN
Sep 27, 2016 GNEA F EXAMINERS AMENDMENT E-MAILED
Sep 27, 2016 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 27, 2016 XAEC I EXAMINER'S AMENDMENT ENTERED
Sep 24, 2016 DOCK D ASSIGNED TO EXAMINER
Jun 21, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 18, 2016 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for use in the treatment and control of bleeding; pharmaceutical preparations and substances, namely, a liposome preparation for use in the treatment and control of bleeding; antifibrinolytic pharmaceutical preparations for per-operative and post-operative use; pharmaceutical preparations, namely, a liposome preparation that is in suspension with pharmaceutical substances for use in the treatment and control of bleeding
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005